StonvexLoading…
StonvexStonvexStonvexCore line items from AVNS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $701.20M | $687.80M | $673.30M | $684.10M |
Operating Income | $-61.60M | $-396.20M | $4.20M | $35.50M |
Net Income | $-72.90M | $-392.10M | $-61.80M | $50.50M |
EPS (Diluted) | $-1.57 | $-8.53 | $-1.32 | $1.07 |
Total Assets | $1.07B | $1.15B | $1.69B | $1.79B |
Total Liabilities | $295.50M | $325.70M | $456.10M | $495.70M |
Cash & Equivalents | $89.80M | $107.70M | $87.70M | $127.70M |
Free Cash Flow OCF − CapEx | $43.10M | $82.90M | $14.60M | $71.60M |
Shares Outstanding | 46.46M | 45.96M | 46.17M | 46.53M |